Title : Improved response by co-targeting EGFR/EGFRvIII and Src family kinases in human cancer cells.

Pub. Date : 2009 Feb

PMID : 19235590






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We hypothesized that co-targeting the epidermal growth factor receptor (EGFR) and Src with the EGFR inhibitor gefitinib and the Src inhibitor AZD0530 would increase growth inhibition and impede migration. saracatinib epidermal growth factor receptor Homo sapiens
2 We hypothesized that co-targeting the epidermal growth factor receptor (EGFR) and Src with the EGFR inhibitor gefitinib and the Src inhibitor AZD0530 would increase growth inhibition and impede migration. saracatinib epidermal growth factor receptor Homo sapiens